UFP Technologies, Inc. (UFPT)

CIK 0000914156 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-03) · 99.1
Q1-2026 8-K (2026-05-04) · 99.1
Latest FY-2025 8-K (2026-02-24) · 99.1
Q3-2025 8-K (2025-11-03) · 99.1
Q2-2025 8-K (2025-08-05) · 99.1
Q1-2025 8-K (2025-05-07) · 99.1
FY-2024 8-K (2025-02-25) · 99.1
Q3-2024 8-K (2024-11-12) · 99.1
Q2-2024 8-K (2024-08-02) · 99.1
Q1-2024 8-K (2024-05-01) · 99.1
FY-2023 8-K (2024-02-26) · 99.1
Q3-2023 8-K (2023-11-09) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Document and Entity Information
Audit Information
—
Statements
Condensed Consolidated Balance Sheets (current Period Unaudited)
—
Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (current Period Unaudited) (P)
—
Consolidated Balance Sheets (P)
Consolidated Statements of Comprehensive Income
Consolidated Statements of Income
—
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Notes
Accrued Expenses
—
Acquisitions
Basis of Presentation
—
Commitments and Contingencies
—
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
Employee Benefit Plans
—
Equity Method Investment
Fair Value of Financial Instruments
Goodwill and Other Intangible Assets
Income Per Share
—
Income Tax
—
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Inventories
Leases
Net Income Per Share
—
Note 1
Note 10
Note 11
Note 12
Note 13
Note 14
Note 15
Note 16
Note 17
Note 18
Note 19
—
Note 2
Note 20
—
Note 21
—
Note 3
Note 4
Note 5
Note 6
Note 7
Note 8
Note 9
Other Long-term Liabilities
Property, Plant and Equipment
Quarterly Financial Information (unaudited)
—
Receivables and Allowance For Credit Losses
Revenue Recognition
Schedule Ii
—
Segment Data
Share-based Compensation
Subsequent Event
—
Summary of Significant Accounting Policies
—
Supplemental Cash Flow Information